- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02285933
Virtual Reality Exercise for Stroke Rehabilitation in Inpatients Who Are Unable to Stand
Does the Addition of Virtual Reality Training to a Standard Program of Inpatient Rehabilitation Improve Sitting Balance Ability and Function After Stroke? A Blinded Randomized Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction Sitting balance may be affected by stroke, resulting in functional impairment and reduced mobility. Early return of sitting balance predicts greater return of motor function and mobility after stroke. Task-specific therapy is effective but patients must be motivated to perform the exercises repeatedly for the greatest benefit.
Virtual reality training (VRT) allows patients to do exercises while interacting with a video game interface. It is enjoyable and may encourage repetition of therapeutic exercises. Past work in our laboratory showed that standing balance exercises performed with VRT produced additional improvements in gait speed and leg function over traditional inpatient rehabilitation (1). Because of legislative change in Ontario most stroke rehabilitation inpatients today cannot stand independently. There have been no studies on the effect of VRT on sitting balance.
Purpose To assess whether additional sitting balance exercises performed via VRT can improve sitting balance and sitting function (ex. reaching) in stroke rehabilitation inpatients.
Hypothesis The addition of VRT for sitting balance will significantly improve sitting balance and function, beyond the gains realized from traditional inpatient rehabilitation.
Experimental Approach In this blinded randomized control trial funded by the Heart & Stroke Foundation, 76 participants with stroke will be recruited from an inpatient rehabilitation unit. This number will provide enough power to detect a large effect size (0.83) with the primary outcome measure and accounting for a 20% drop-out rate. Individuals who are medically stable and who can sit for at least 20 minutes with or without trunk support but cannot stand independently for more than one minute will be eligible. These criteria will target our selection to those who need to work most on sitting balance. Participants will be randomized into experimental and control groups.
Participants in both groups will perform VRT for 30-50 minutes daily for 10-12 sessions, in addition to their rehabilitation program. VRT will be delivered with Jintronix software and motion capture technology. Exercises for the experimental group will challenge sitting balance control, reaching and shifting the base of support. Control group exercises will require limited hand and arm movements, to equalize the additional time spent in an engaging activity without working on trunk balance. Control group participants will be strapped into their chair to minimize trunk movement. A CONFORMat pressure mat will be used to monitor centre of pressure changes during the intervention.
Outcome measures will be performed pre-, post- and 1 month post-intervention, by an assessor blinded to group allocation. The primary outcome measure will be the Function in Sitting Test. Secondary outcome measures will be: Ottawa Sitting Scale, Reaching Performance Scale, Wolf Motor Function Test and quantitative measures of postural control performed in sitting. Two-way analyses of variance [factors: time (pre-, post-, 1 month post-)and group(experimental, control)] and Tukey's post-hoc analyses will be used to test the effect of VRT on the outcome measures.
Significance and Knowledge Translation If we show that the addition of sitting balance exercises via VRT to traditional rehabilitation improves sitting balance and function, VRT may be added to inpatients' rehabilitation therapy. The ultimate goal is to improve the quality of patients' lives and decrease the burden on their caregivers. Since the Jintronix system is portable, we hope to acquire funding for several units. We would then be able to assess the use of VRT by therapists for inpatients and outpatients with stroke.
(1) McEwen D et al. Stroke 2014;45:1853-1855
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N 5C8
- Elisabeth Bruyère Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ischemic or hemorrhagic stroke in the left or right cortical or subcortical regions
- medically stable
- cannot stand independently for >1 minute or cannot stand at all
- can sit for at least 20 minutes with or without trunk support and can sit for at least 1 minute without trunk support
- able to provide informed consent
Exclusion Criteria:
- unstable cardiovascular, respiratory, endocrine, orthopedic or neurological condition that precludes exercise of low to moderate intensity
- vestibular deficits or vertigo
- seizure activity in the previous 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VRT
sitting balance exercises delivered via virtual reality training
|
Each participant will engage in 10-12 sessions of 30-50 minutes each of virtual reality training (VRT) using Jintronix Rehabilitation Software and three-dimensional motion capture technology.
A camera captures the movements of the participant and allows him or her to control an avatar, which interacts with the game.
Exercises challenge sitting balance control, reaching and shifting the base of support; for example, controlling a ball as it rolls down a maze or reaching to put dishes away in a virtual kitchen.
The difficulty of the games is monitored to maintain a challenge to sitting balance.
The participant sits on a CONFORMat pressure mat which continuously monitors his or her centre of pressure to ensure that the participant is adequately challenged during the VRT.
|
Active Comparator: control
virtual reality training requiring limited arm movements and no challenge to sitting balance
|
Each participant will engage in 10-12 sessions of 30-50 minutes each of virtual reality training (VRT) using Jintronix Rehabilitation Software and three-dimensional motion capture technology.
A camera captures the movements of the participant and allows him or her to control an avatar, which interacts with the game.
Control group exercises require limited hand and arm movements; for example, using an arm to move a fish along a simple pathway or using the arms to pop balloons without reaching.
Control group participants are strapped into their chair to minimize trunk movement.
The participant sits on a CONFORMat pressure mat which continuously monitors his or her centre during the VRT.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Function In Sitting Test (FIST) from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses static, dynamic and reactional sitting balance
|
baseline, immediately after 10-12 treatments
|
Change in the Function In Sitting Test (FIST) from baseline to 1 month after second assessment
Time Frame: baseline,1 month after second assessment
|
assesses static, dynamic and reactional sitting balance
|
baseline,1 month after second assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Ottawa Sitting Scale (OSS) from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses static and dynamic sitting balance
|
baseline, immediately after 10-12 treatments
|
Change in the Ottawa Sitting Scale (OSS) from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
assesses static and dynamic sitting balance
|
baseline, 1 month after second assement
|
Change in Limits of stability in sitting (LoS) from baseline to after 10-12 treatment sessions
Time Frame: before treatment, immediately after 10-12 treatments
|
assesses dynamic sitting balance using a force plate or pressure mat
|
before treatment, immediately after 10-12 treatments
|
Change in Limits of stability in sitting (LoS) from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
assesses dynamic sitting balance using a force plate or pressure mat
|
baseline, 1 month after second assement
|
Change in Postural sway in sitting from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses static sitting balance using a force plate or pressure mat
|
baseline, immediately after 10-12 treatments
|
Change in Postural sway in sitting from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
assesses static sitting balance using a force plate or pressure mat
|
baseline, 1 month after second assement
|
Change in the Reaching Performance Scale (RPS) from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses sitting balance function during reaching
|
baseline, immediately after 10-12 treatments
|
Change in the Reaching Performance Scale (RPS) from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
assesses sitting balance function during reaching
|
baseline, 1 month after second assement
|
Change in the Wolf Motor Function Test (WMFT) from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses sitting balance function using global arm function
|
baseline, immediately after 10-12 treatments
|
Change in the Wolf Motor Function Test (WMFT) from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
assesses sitting balance function using global arm function
|
baseline, 1 month after second assement
|
Change in The Motivation for Physical Activity Questionnaire from baseline to after 10-12 treatment sessions
Time Frame: before treatment, immediately after 10-12 treatments
|
Likert scale from 0-6 to assess motivation to engage in exercise
|
before treatment, immediately after 10-12 treatments
|
Change in The Motivation for Physical Activity Questionnaire from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assement
|
Likert scale from 0-6 to assess motivation to engage in exercise
|
baseline, 1 month after second assement
|
Change in the Behavioral Regulation in Exercise Questionnaire (BREQ-2) from baseline to after 10-12 treatment sessions
Time Frame: baseline, immediately after 10-12 treatments
|
assesses quality of motivation to engage in exercise
|
baseline, immediately after 10-12 treatments
|
Change in the Behavioral Regulation in Exercise Questionnaire (BREQ-2) from baseline to 1 month after second assessment
Time Frame: baseline, 1 month after second assessment
|
assesses quality of motivation to engage in exercise
|
baseline, 1 month after second assessment
|
Psychosocial Impact of Assistive Devices Scale (PIADS)
Time Frame: immediately after 10-12 treatments
|
assesses the psychosocial impact of assistive devices or technology on "functional independence, well-being and quality of life"
|
immediately after 10-12 treatments
|
Psychosocial Impact of Assistive Devices Scale (PIADS)
Time Frame: 1 month after first assement
|
assesses the psychosocial impact of assistive devices or technology on "functional independence, well-being and quality of life"
|
1 month after first assement
|
The ability to enroll an average of five new participants a month, to obtain a consent rate of 60% of eligible patients and a rate of protocol violations resulting in noncompliance with VRT of less than 10%.
Time Frame: immediately after 76 participants have finished the protocol and assessments
|
assesses the feasibility of performing a larger multicentre trial of VRT with rehabilitation inpatients
|
immediately after 76 participants have finished the protocol and assessments
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Hillel M Finestone, MD, Bruyère Research Institute
- Study Director: Heidi Sveistrup, PhD, University of Ottawa
- Study Director: Martin Bilodeau, PhD, University of Ottawa
Publications and helpful links
General Publications
- McEwen D, Taillon-Hobson A, Bilodeau M, Sveistrup H, Finestone H. Virtual reality exercise improves mobility after stroke: an inpatient randomized controlled trial. Stroke. 2014 Jun;45(6):1853-5. doi: 10.1161/STROKEAHA.114.005362. Epub 2014 Apr 24.
- Sheehy L, Taillon-Hobson A, Sveistrup H, Bilodeau M, Fergusson D, Levac D, Finestone H. Does the addition of virtual reality training to a standard program of inpatient rehabilitation improve sitting balance ability and function after stroke? Protocol for a single-blind randomized controlled trial. BMC Neurol. 2016 Mar 31;16:42. doi: 10.1186/s12883-016-0563-x.
- Sheehy L, Taillon-Hobson A, Sveistrup H, Bilodeau M, Finestone H. Implementation of a randomized controlled trial on an inpatient stroke rehabilitation unit: Lessons learned. Contemp Clin Trials Commun. 2020 Apr 6;18:100563. doi: 10.1016/j.conctc.2020.100563. eCollection 2020 Jun.
- Sheehy L, Taillon-Hobson A, Sveistrup H, Bilodeau M, Yang C, Finestone H. Sitting Balance Exercise Performed Using Virtual Reality Training on a Stroke Rehabilitation Inpatient Service: A Randomized Controlled Study. PM R. 2020 Aug;12(8):754-765. doi: 10.1002/pmrj.12331. Epub 2020 Feb 21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G-14-0005830
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on virtual reality training
-
University of California, Los AngelesSuspendedDepression | Mood Disorders | Anhedonia | Stress | Anxiety | Virtual RealityUnited States
-
Riphah International UniversityCompleted
-
Luzerner KantonsspitalRecruitingParkinson DiseaseSwitzerland
-
IRCCS Eugenio MedeaUniversidad de Burgos; Asociatia Bucuresti Pentru Copii Dislexici; Augumented...Completed
-
Universidade do Oeste PaulistaUnknownCardiovascular Diseases | Body CompositionBrazil
-
Indiana UniversityCompletedAdolescent | Child | Attention Deficit and Disruptive Behavior Disorders | Conduct Disorder | Magnetic Resonance Imaging | Virtual Reality | Child Behavior Disorders | Social PerceptionUnited States
-
TOPMEDConseil de recherches en sciences naturelles et en génie du Canada; SEC Fonds...Recruiting
-
Vanderbilt UniversityUniversity of California, San DiegoCompleted
-
Mental Health Services in the Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; TrygFonden, DenmarkRecruitingDepression | Psychotic Disorders | Schizophrenia | Cognitive Impairment | Bipolar Disorder | Schizotypal DisorderDenmark
-
University of California, Los AngelesRecruiting